Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Renalytix (RNLXY)
OTHER OTC:RNLXY
Holding RNLXY?
Track your performance easily
RNLXY Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.12 - $2.40
Previous Close$0.14
Volume116.90K
Average Volume (3M)188.30K
Market Cap
$32.72M
Enterprise Value$40.06M
Total Cash (Recent Filing)$909.00K
Total Debt (Recent Filing)$8.25M
Price to Earnings (P/E)―
Beta0.85
Next Earnings
Mar 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.51
Shares Outstanding165,603,006
10 Day Avg. Volume60,972
30 Day Avg. Volume188,297
Standard Deviation0.48
R-Squared0.07
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)-2.27
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue17.03
Enterprise Value/Gross Profit256.80
Enterprise Value/Ebitda-1.91
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Ownership Overview
21.14% Insiders
0.03% Mutual Funds
1.33% Other Institutional Investors
77.50% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
RNLXY FAQ
What was Renalytix’s price range in the past 12 months?
Renalytix lowest stock price was $0.12 and its highest was $2.40 in the past 12 months.
What is Renalytix’s market cap?
Currently, no data Available
When is Renalytix’s upcoming earnings report date?
Renalytix’s upcoming earnings report date is Mar 27, 2025 which is in 95 days.
How were Renalytix’s earnings last quarter?
Currently, no data Available
Is Renalytix overvalued?
According to Wall Street analysts Renalytix’s price is currently Overvalued.
Does Renalytix pay dividends?
Renalytix does not currently pay dividends.
What is Renalytix’s EPS estimate?
Renalytix’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Renalytix have?
Renalytix has 165,603,010 shares outstanding.
What happened to Renalytix’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Renalytix?
Among the largest hedge funds holding Renalytix’s share is Gilder Gagnon Howe & Co LLC.. It holds Renalytix’s shares valued at N/A.
---
Renalytix Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
RNLXY Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 761.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 9.8%
Last 30 Days ▼ 9.8%
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-75.47%
Trailing 12-Months
Company Description
Renalytix
Renalytix AI PLC is a developer of artificial intelligence-enabled clinical decision support solutions for kidney disease and costly chronic medical conditions globally. The company's solutions are being designed to make significant improvements in kidney disease risk assessment, clinical care, patient stratification for drug clinical trials, and drug target discovery.
---
RNLXY Earnings Call
Q3 2024
0:00 / 0:00
---
RNLXY Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering RNLXY
1 Year
1 Year Success Rate
1/17 ratings generated profit
1 Year Average Return
-65.28%
reiterated a buy rating 7 months ago
Copying Mark Massaro's trades and holding each position for 1 Year would result in 5.88% of your transactions generating a profit, with an average return of -65.28% per trade.
---